Cargando…
Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic Syndrome
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases, which has recently been mentioned as an independent cardiovascular risk factor. OBJECTIVES: Endocan is a novel molecule of endothelial dysfunction. We aimed to evaluate the associations of serum en...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152978/ https://www.ncbi.nlm.nih.gov/pubmed/32317862 http://dx.doi.org/10.1155/2020/3534042 |